Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Amino Ketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1043229C details a novel route for beta-aminovinyl ketones, offering cost reduction in herbicide manufacturing and reliable supply chain solutions.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Novel electrochemical method for beta-arylamino ketones. Green, sustainable, metal-free. Reliable pharmaceutical intermediates supplier.
Patent CN110003110B reveals a green photocatalytic route for aryl beta-aminoketones, offering cost reduction and mild conditions for pharmaceutical manufacturing.
Patent CN108147989B reveals a one-pot synthesis of beta-amino ketones using allyl alcohols, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Novel acid-catalyzed one-pot synthesis patent CN106883152A offers high yield and atom economy for reliable pharmaceutical intermediate supply chains.
Patent CN1110476C reveals a streamlined route to beta-diketones, offering significant cost reduction in herbicide manufacturing and enhanced supply chain reliability for global buyers.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN114213254B details a visible-light mediated synthesis of beta-nitroketones. Offers high yield, mild conditions, and scalable routes for pharmaceutical intermediates.
Novel nickel catalyzed carbonylation method offers cost effective high purity beta aminoketone derivatives for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN121021342A reveals a mild nickel-catalyzed method for beta-aminoketone derivatives, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN121021342A reveals a mild nickel-catalyzed method for beta-aminoketones using formic acid, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
This nickel-catalyzed synthesis method enables high-purity API intermediates with reduced manufacturing costs and faster commercial scale-up for pharmaceutical supply chains.